Búsqueda | Portal de Búsqueda de la BVS España

1.

Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.

Mack, Douglas P; Dribin, Timothy E; Turner, Paul J; Wasserman, Richard L; Hanna, Mariam A; Shaker, Marcus; Tang, Mimi L K; Rodríguez Del Río, Pablo; Sobolewski, Brad; Abrams, Elissa M; Anagnostou, Aikaterini; Arasi, Stefania; Bajowala, Sakina; Bégin, Philippe; Cameron, Scott B; Chan, Edmond S; Chinthrajah, Sharon; Clark, Andrew T; Detjen, Paul; du Toit, George; Ebisawa, Motohiro; Elizur, Arnon; Factor, Jeffrey M; Greiwe, Justin; O'B Hourihane, Jonathan; Hughes, Sarah W; Jones, Douglas H; Muraro, Antonella; Nowak-Wegrzyn, Anna; Patel, Nandinee B; Scurlock, Amy M; Shah, Atul N; Sindher, Sayantani B; Tilles, Stephen; Vickery, Brian P; Wang, Julie; Windom, Hugh H; Greenhawt, Matthew.

J Allergy Clin Immunol; 2024 Mar 28.

Artículo en Inglés | MEDLINE | ID: mdl-38597862

2.

Information needs of patients considering oral immunotherapy for food allergy.

Mack, Douglas Paul; Greenhawt, Matthew; Turner, Paul J; Wasserman, Richard L; Hanna, Mariam A; Shaker, Marcus; Hughes, Sarah W; Del Río, Pablo Rodríguez.

Clin Exp Allergy; 52(12): 1391-1402, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36083693

3.

Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment.

Wasserman, Richard L.

Allergy Asthma Proc; 42(6): 489-494, 2021 11 01.

Artículo en Inglés | MEDLINE | ID: mdl-34871156

4.

Microbiological, Physicochemical, and Immunological Analysis of a Commercial Cashew Nut-Based Yogurt.

Mattison, Christopher P; Aryana, Kayanush J; Clermont, Kristen; Prestenburg, Eric; Lloyd, Steven W; Grimm, Casey C; Wasserman, Richard L.

Int J Mol Sci; 21(21)2020 Nov 04.

Artículo en Inglés | MEDLINE | ID: mdl-33158240

5.

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.

Ballow, Mark; Wasserman, Richard L; Jolles, Stephen; Chapel, Helen; Berger, Mel; Misbah, Siraj A.

J Clin Immunol; 38(4): 539, 2018 May.

Artículo en Inglés | MEDLINE | ID: mdl-29713933

6.

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.

Jolles, Stephen; Rojavin, Mikhail A; Lawo, John-Philip; Nelson, Robert; Wasserman, Richard L; Borte, Michael; Tortorici, Michael A; Imai, Kohsuke; Kanegane, Hirokazu.

J Clin Immunol; 38(8): 864-875, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-30415311

7.

Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients.

Heimall, Jennifer R; Hagin, David; Hajjar, Joud; Henrickson, Sarah E; Hernandez-Trujillo, Hillary S; Itan, Yuval; Kobrynski, Lisa; Paris, Kenneth; Torgerson, Troy R; Verbsky, James W; Wasserman, Richard L; Hsieh, Elena W Y; Bleesing, Jack J; Chou, Janet S; Lawrence, Monica G; Marsh, Rebecca A; Rosenzweig, Sergio D; Orange, Jordan S; Abraham, Roshini S.

J Clin Immunol; 38(4): 540-541, 2018 May.

Artículo en Inglés | MEDLINE | ID: mdl-29781065

8.

Use of Genetic Testing for Primary Immunodeficiency Patients.

Heimall, Jennifer R; Hagin, David; Hajjar, Joud; Henrickson, Sarah E; Hernandez-Trujillo, Hillary S; Tan, Yuval; Kobrynski, Lisa; Paris, Kenneth; Torgerson, Troy R; Verbsky, James W; Wasserman, Richard L; Hsieh, Elena W Y; Blessing, Jack J; Chou, Janet S; Lawrence, Monica G; Marsh, Rebecca A; Rosenzweig, Sergio D; Orange, Jordan S; Abraham, Roshini S.

J Clin Immunol; 38(3): 320-329, 2018 04.

Artículo en Inglés | MEDLINE | ID: mdl-29675737

9.

Traveling with primary immunodeficiency.

Wasserman, Richard L.

Ann Allergy Asthma Immunol; 130(4): 422-424.e4, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-36441081

10.

Reply to high cost of immunoglobulin replacement therapy: Causes and implications.

Wasserman, Richard L.

Ann Allergy Asthma Immunol; 130(2): 258, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36368644

11.

Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.

Shapiro, Ralph S; Wasserman, Richard L; Bonagura, Vincent; Gupta, Sudhir.

J Clin Immunol; 37(2): 190-196, 2017 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-24477950

12.

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.

Wasserman, Richard L; Ito, Diane; Xiong, Yan; Ye, Xiaolan; Bonnet, Patrick; Li-McLeod, Josephine.

J Clin Immunol; 37(2): 180-186, 2017 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-28160239

13.

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex^® 10% Versus Gammaplex^® 5% in Subjects with Primary Immunodeficiency.

Wasserman, Richard L; Melamed, Isaac R; Stein, Mark R; Jolles, Stephen; Norton, Miranda; Moy, James N.

J Clin Immunol; 37(3): 301-310, 2017 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-28316003

14.

Immunoglobulin replacement therapy stewardship in modern times.

Wasserman, Richard L.

Ann Allergy Asthma Immunol; 129(5): 546-547, 2022 11.

Artículo en Inglés | MEDLINE | ID: mdl-35568299

15.

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.

Wasserman, Richard L; Lumry, William; Harris, James; Levy, Robyn; Stein, Mark; Forbes, Lisa; Cunningham-Rundles, Charlotte; Melamed, Isaac; Kobayashi, Ai Lan; Du, Wei; Kobayashi, Roger.

J Clin Immunol; 36(6): 590-9, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27324887

16.

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.

Wasserman, Richard L; Melamed, Isaac; Stein, Mark R; Engl, Werner; Sharkhawy, Marlies; Leibl, Heinz; Puck, Jennifer; Rubinstein, Arye; Kobrynski, Lisa; Gupta, Sudhir; Grant, Andrew J; Ratnayake, Anoshie; Richmond, Wendell G; Church, Joseph; Yel, Leman; Gelmont, David.

J Clin Immunol; 36(6): 571-82, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27220317

17.

Exploiting nut cross-reactivity to facilitate real-world treatment of tree nut allergy.

Wasserman, Richard L; Windom, Hugh H; Lie, Daria; Pence, Deanna M; Ly, Jean.

Ann Allergy Asthma Immunol; 127(1): 149-151, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-33848631

18.

Common variable immunodeficiency and respiratory complications: take-home messages for the clinician.

Wasserman, Richard L.

Ann Allergy Asthma Immunol; 124(5): 414-415, 2020 05.

Artículo en Inglés | MEDLINE | ID: mdl-32336461

19.

Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease.

Jolles, Stephen; Borte, Michael; Nelson, Robert P; Rojavin, Mikhail; Bexon, Martin; Lawo, John-Philip; Wasserman, Richard L.

Clin Immunol; 150(2): 161-9, 2014 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-24412910

20.

Captaining the PIDD ship.

Wasserman, Richard L.

Ann Allergy Asthma Immunol; 123(5): 419, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31676017

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.

Information needs of patients considering oral immunotherapy for food allergy.

Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment.

Microbiological, Physicochemical, and Immunological Analysis of a Commercial Cashew Nut-Based Yogurt.

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.

Correction to: Use of Genetic Testing for Primary Immunodeficiency Patients.

Use of Genetic Testing for Primary Immunodeficiency Patients.

Traveling with primary immunodeficiency.

Reply to high cost of immunoglobulin replacement therapy: Causes and implications.

Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex^® 10% Versus Gammaplex^® 5% in Subjects with Primary Immunodeficiency.

Immunoglobulin replacement therapy stewardship in modern times.

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.

Exploiting nut cross-reactivity to facilitate real-world treatment of tree nut allergy.

Common variable immunodeficiency and respiratory complications: take-home messages for the clinician.

Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease.

Captaining the PIDD ship.